SCHEMBL1522402

SCHEMBL1522402

O=c1oc(=O)n(Cc2cccc(Cl)c2)c2ncccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.55
HPGD P15428 3/20 0.50
KDM4E B2RXH2 2/20 0.50
HTT P42858 2/20 0.50
ALDH1A1 P00352 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MAPT P10636 8/20 0.48
THRB P10828 1/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.44
GAA P10253 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43
PDE1B Q01064 2/20 0.43
USP2 O75604 1/20 0.43
IDO1 P14902 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522698 0.87 PTGDR2 (0.51) PTGDR2KDM4EALDH1A1MAPTTHRB
SCHEMBL1522600 0.85 MAPT (0.43) PTGDR2KDM4EALDH1A1MAPTTHRB
SCHEMBL1523014 0.85 MAPT (0.63) KDM4EMAPTTHRBTP53LMNA
SCHEMBL1522322 0.85 MEN1 (0.52) PTGDR2HPGDKDM4EALDH1A1MAPT
SCHEMBL1522224 0.85 MAPT (0.46) PTGDR2HPGDKDM4EALDH1A1MAPT
SCHEMBL1523043 0.85 MAPT (0.46) PTGDR2KDM4EALDH1A1MAPTTHRB
SCHEMBL1523366 0.83 PTGDR2 (0.51) PTGDR2KDM4EALDH1A1MAPTTHRB
SCHEMBL1522408 0.82 MAPT (0.43) PTGDR2MAPTTHRB
SCHEMBL1523692 0.82 MAPT (0.65) KDM4EALDH1A1MAPTTHRBMAPK1
SCHEMBL1522904 0.82 ABHD6 (0.47) PTGDR2HPGDMAPTTHRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361913-A1 Anti-infective agents Abbott Laboratories (US) 2011-08-31 EP disclosed
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB PTGDR2 4141/4885HPGD 1599/4885KDM4E 4352/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB PTGDR2 4141/4885HPGD 1599/4885KDM4E 4352/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 PTGDR2 4076/4885HPGD 1753/4885KDM4E 4075/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT PTGDR2 4088/4885HPGD 1364/4885KDM4E 3897/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB PTGDR2 4141/4885HPGD 1599/4885KDM4E 4352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.